ML141
CAS No. 71203-35-5
ML141 ( CID2950007 )
Catalog No. M15727 CAS No. 71203-35-5
ML141 is a potent, selective and reversible non-competitive inhibitor of Rho family GTPase cdc42 with IC50 of 200 nM.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 41 | In Stock |
|
5MG | 59 | In Stock |
|
10MG | 101 | In Stock |
|
25MG | 212 | In Stock |
|
50MG | 385 | In Stock |
|
100MG | 551 | In Stock |
|
500MG | 1188 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML141
-
NoteResearch use only, not for human use.
-
Brief DescriptionML141 is a potent, selective and reversible non-competitive inhibitor of Rho family GTPase cdc42 with IC50 of 200 nM.
-
DescriptionML141 is a potent, selective and reversible non-competitive inhibitor of Rho family GTPase cdc42 with IC50 of 200 nM.
-
SynonymsCID2950007
-
PathwayAngiogenesis
-
TargetCDK
-
Recptorcdc42
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number71203-35-5
-
Formula Weight407.49
-
Molecular FormulaC22H21N3O3S
-
Purity>98%(HPLC)
-
SolubilityDMSO: 81 mg/mL warmed (198.77 mM)
-
SMILESO=S(C1=CC=C(N2N=C(C3=CC=CC=C3)CC2C4=CC=C(OC)C=C4)C=C1)(N)=O
-
Chemical Name4-[4,5-dihydro-5-(4-methoxyphenyl)-3-phenyl-1H-pyrazol-1-yl]-benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chen HY, et al. EMBO Mol Med. 2013, 5(5), 723-736.
molnova catalog
related products
-
Voruciclib
A potent, selective and orally bioavailable CDK9 inhibitor with Ki of 0.63 nM and 1.68 nM for CDK9/cyclinT2 and CDK9/cyclinT1, respectively.
-
CDK4-IN-1
CDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM.
-
Indirubin-3-monoxime
Indirubin-3-monoxime is an effective inhibitor of cyclin-dependent protein kinases, and may play an obligate role in neuronal apoptosis in Alzheimer's disease.